amlodipine and dihydropyridines

amlodipine has been researched along with dihydropyridines in 235 studies

Research

Studies (235)

TimeframeStudies, this research(%)All Research%
pre-19905 (2.13)18.7374
1990's33 (14.04)18.2507
2000's84 (35.74)29.6817
2010's100 (42.55)24.3611
2020's13 (5.53)2.80

Authors

AuthorsStudies
Heynen, G1
Mason, RP; Moisey, DM; Shajenko, L1
Arena, JP; Chin, S; Kass, RS2
Herbette, LG; Mason, RP; Moring, J1
Bolger, GT; O'Neill, SK1
Gambini, F; Gaviraghi, G; Micheli, D; Quartaroli, M; Tarter, G; Trist, DG1
Alker, D; Beresford, AP; Kobylecki, RJ; Macrae, PV1
Fleckenstein, A; Fleckenstein-Grün, G; Frey, M; Zorn, J1
Matlib, MA1
Arrowsmith, JE; Blackburn, KJ; Burges, RA; Campbell, SF; Cross, PE; Gardiner, DG; Stubbs, JK1
Lombardo, D; Raimondi, F1
Hattori, K; Maruyama, K; Nagatomo, T; Qu, YL; Sugiyama, K; Takamizawa, C; Watanabe, K1
Karasawa, A; Moriyama, T1
Abrahamsson, T; Akerblom, B; Nordlander, M; Thalén, P1
Bangalore, R; Glossmann, H; Kass, RS; Kwan, YW; Lakitsh, M1
Elliott, HL1
Mason, RP1
Locher, R; Lupo, E; Vetter, W; Weisser, B1
Gaviraghi, G; Giacometti, A; Micheli, D; Trist, DG1
Vetrovec, GW1
Bachetti, T; Carboni, L; Ferri, S; Ratti, E; Spampinato, S; Van Amsterdam, FT1
Block, LH; Nauck, M; Rödler, S; Roth, M; Tamm, M1
Block, LH; Eickelberg, O; Erne, P; Kohler, E; Roth, M1
Gilar, M; Tesarová, E; Uhrová, M1
Cheung, BM; Lau, CP1
Karasawa, A; Kusaka, H; Nomura, H1
Fujiki, H; Hirano, T; Miyakoda, G; Mori, T; Ohura, M; Orito, K1
Crouzel, C; Dollé, F; Duval, R; Fuseau, C; Hinnen, F; Péglion, JL; Valette, H1
Heath, B; Kass, RS; Xia, J1
Haraguchi, K; Iga, T; Ito, K; Kotaki, H; Sawada, Y1
Fujiki, H; Hata, F; Hirano, T; Miyakoda, G; Mori, T; Nakaya, Y; Ohura, M; Orito, K; Satake, H; Sumida, T; Takeuchi, T; Yamamura, Y; Yoshida, K1
Böhm, M; Bräsen, JH; Griendling, KK; Harrison, DG; Heitzer, T; Macharzina, R; Meinertz, T; Münzel, T; Nickenig, G; Schulz, E; Skatchkov, M; Stasch, JP; Warnholtz, A1
Miho, N; Nawada, R; Obayashi, K; Sakata, K; Shirotani, M; Togi, K; Yoshida, H1
Karasawa, A; Kobayashi, S; Kosaka, N; Nito, M; Nomura, H; Sonoda, R; Tanaka, H; Yamaguchi, K1
Christians, T; Diewald, D; Holzgrabe, U; Lehmann, J; Otte, Y; Wessler, C1
Birkenhäger, WH; Fagard, RH; Staessen, JA1
Fukuo, K; Morimoto, S; Niinobu, T; Ogihara, T; Suhara, T; Yang, J1
de Vries, RJ; Dunselman, PH; van Veldhuisen, DJ1
Di Nicola, G; Joffe, BI; Klug, E; Panz, V; Stankovic, S1
Fukuzawa, M; Miyaguchi, S; Nakazawa, T; Ohta, S; Qiang, X; Sakata, Y; Satoh, J; Takahashi, K; Takizawa, Y; Toyota, T1
Antepohl, W; Haaf, O; Herzig, S; Huber, I; Matthes, J; Striessnig, J1
Hirano, K; Kimura, R; Ohashi, K; Urayama, A; Watanabe, H; Yamada, S1
Araki, H; Futagami, K; Gomita, Y; Kawasaki, H; Kurosaki, Y; Nakatsuma, A1
Corradi, L; Fogari, R; Malalamani, GD; Mugellini, A; Preti, P; Zoppi, A1
Kumari, S; Malhotra, S; Pandhi, P1
Hirano, T; Kambe, T; Mori, T; Nakayama, N; Schwartz, A; Takase, H; Toide, K1
Andrésdóttir, MB; Huysmans, FT; Valk, IM; van de Bosch, WJ; van Hamersvelt, HW; van Helden, MJ1
Garcha, RS; Hughes, AD; Sever, PS1
De Cesaris, R; La Commare, P; Omboni, S; Palatini, P; Zanchetti, A1
Agabiti-Rosei, E; Castellano, M; de Kam, PJ; Fallon, M; Fluckiger, L; Hausberg, M; Heitmann, J; Lefrandt, JD; Murphy, M; Rahn, KH; Rostrup, M; Sevre, K; Smit, AJ; Urbigkeit, A; van Roon, AM; Zannad, F1
Godfraind, T; Krenek, P; Kyselovic, J; Wibo, M1
Doba, N; Kimura, Y; Kinouchi, T; Kuwabara, Y; Kuwata, S; Maruyama, C; Tomiyama, H; Yoshida, H; Yoshida, Y1
Bakris, GL; Epstein, M; Goldberg, R; Hung, E; Preston, R; Richardson, DJ; Smith, AC1
Christians, T; Holzgrabe, U1
Kimura, R; Kusaka, T; Nakajima, M; Uchida, S; Yamada, S1
Bianchetti, MG; Edefonti, A; Fossali, E; Vogt, B; von Vigier, RO1
Leonetti, G; Magnani, B; Pessina, AC; Rappelli, A; Trimarco, B; Zanchetti, A1
Szász, G1
Zanchetti, A1
Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Liao, Y; Minamino, T; Node, K; Ogai, A; Ogita, H; Sanada, S; Takashima, S1
Campagnola, M; Cominacini, L; Davoli, A; Fratta Pasini, A; Garbin, U; Lo Cascio, V; Nava, C; Pastorino, AM; Rossato, P1
Hirai, A; Ichikawa, S; Kanada, S; Kuramoto, K; Nakachi, T; Ogihara, T1
Helberg, S; Istad, H; Lund-Johansen, P; Madsbu, S; Risberg, K; Rønnevik, PK; Stranden, E; Wessel-Aas, T1
Boatto, G; de Caprariis, P; Faedda, MV; Nieddu, M1
Balbarini, A; Dell'Omo, G; Mariani, M; Menegato, A; Nuti, M; Pedrinelli, R1
Inomata, K; Tanaka, H1
Shigematsu, M; Takami, T1
Imaizumi, T; Inagaki, Y; Nakamura, K; Yamagishi, S1
Kojima, S; Shida, M; Yokoyama, H1
Miyachi, Y; Ueshiba, H1
Fukumoto, Y; Ito, A; Shimokawa, H1
Enomoto, A; Konda, T; Matsushita, J; Moriyama, T; Takahara, A1
Brazdzionyte, J; Jurkevicius, R; Zabiela, V; Zaliūnas, R1
Brazdzionyte, J; Jurkevicus, R; Zabiela, V; Zaliunas, R1
Brixius, K; Geissler, HJ; Gross, T; Hekmat, K; Mehlhorn, U; Schwinger, RH; Tossios, P1
Asayama, J; Inoue, R; Kobara, M; Miki, S; Nakagawa, Y; Nakata, T; Shimizu, T; Toba, H; Yoshimura, A1
Aizawa, Y; Gurusamy, N; Kamal, FA; Kodama, M; Kunisaki, M; Ma, M; Mito, S; Palaniyandi, SS; Prakash, P; Veeraveedu, PT; Wahed, MI; Watanabe, K; Wen, J1
Eguchi, K; Hoshide, S; Ishikawa, J; Kario, K; Shimada, K1
Abe, Y; Fan, YY; Fujisawa, Y; Kimura, S; Kiyomoto, H; Kohno, M; Nishiyama, A; Rahman, M; Shokoji, T; Sun, GP1
Ito, T; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T1
Hayashi, K; Iigaya, K; Kumagai, H; Onami, T; Takimoto, C1
Inoue, T; Kobayashi, K; Nakamoto, H; Shoda, J; Suzuki, H1
Aizawa, Y; Atarashi, H; Fukatani, M; Hirai, M; Hirayama, A; Inoue, H; Kamakura, S; Kato, T; Kodama, I; Koretsune, Y; Kumagai, K; Kurachi, Y; Mitamura, H; Nakaya, H; Ogawa, S; Ohe, T; Ohtsu, H; Okumura, K; Saikawa, T; Sakurai, M; Sugi, K; Watanabe, E; Yamashita, T; Yamazaki, T1
Ikeda, J; Matsubara, M; Yao, K2
Ishibashi, T; Nishio, M; Yoshida, J1
Yamagishi, T1
Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y1
Eguchi, K; Fukuda, T; Hoshide, S; Ishikawa, J; Kario, K; Numao, T; Shimada, K; Tomizawa, H1
Alberici, M; Lembo, G; Payeras, AC; Sladek, K1
Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M1
Iwasaka, T; Maki, K; Morimoto, S; Yano, Y1
Fujitani, Y; Hirose, T; Kanazawa, A; Kawamori, R; Ohmura, C; Sakai, K; Shimizu, T; Uchino, H; Watada, H1
Abe, K; Deguchi, K; Hayashi, T; Kamiya, T; Lukic-Panin, V; Sehara, Y; Tsuchiya, A; Yamashita, T; Zhang, H1
Fujii, M; Horie, M; Sakai, H; Tanaka, T; Tsutamoto, T; Yamamoto, T1
Borekci, B; Cadirci, E; Halici, Z; Ozdemir, Y; Suleyman, H1
Ando, K; Fujita, T; Ideura, T; Isshiki, M; Nishimura, H; Takahashi, K; Yasuda, G1
Ali, N; Palit, P1
Fujiwara, H; Hattori, A; Hiei, K; Io, K; Kato, T; Kawasaki, M; Matsuo, H; Minatoguchi, S; Morita, N; Nishigaki, K; Noda, T; Ojio, S; Ono, H; Sato, H; Segawa, T; Takemura, G; Tanaka, T; Ueno, K; Watanabe, S1
Hayashi, N; Ito, N; Katsuya, T; Ogihara, T; Ohishi, M; Rakugi, H; Shiota, A; Takagi, T; Tatara, Y; Terai, M1
Dickson, M; Plauschinat, CA1
Barrios, V; Calderón, A; de la Figuera, M; Escobar, C; Honorato, J; Llisterri, JL; Segura, J2
Fukumoto, Y; Ito, A; Shimokawa, H; Yasuda, S1
Cadirci, E; Halici, Z; Suleyman, H1
Martinez-Martin, FJ; Saiz-Satjes, M1
Furuno, M; Higaki, J; Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Okayama, H; Senba, I; Tomono, Y1
Ishii, K; Kawakami, T; Kuwagata, M; Nakahara, T; Saito, M; Sakamoto, K; Shimada, M; Yamaguchi, A1
Abe, M; Maruyama, N; Maruyama, T; Matsumoto, K; Okada, K1
Chiba, S; Fujisawa, M; Koike, H; Yorikane, R1
Aritomi, S; Enomoto, A; Koganei, H; Konda, T; Niinuma, K; Nitta, K; Ogawa, T1
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tanaka, T; Tsutamoto, T; Yamaji, M; Yamamoto, T1
Fujita, T; Fujito, T; Hishikawa, K; Idei, M; Takase, O1
Martínez Martín, FJ1
Araki, N; Furuya, D; Ohkubo, T; Shimazu, K; Takei, K; Tamura, N; Yamamoto, T; Yanagisawa, CT1
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohhira, M; Oyama, T; Saiki, A; Sasaki, H; Shirai, K; Yamaguchi, T1
Daida, H; Fujiwara, Y; Inoue, K; Kawamura, M; Kojima, T; Kurata, T; Miyauchi, K; Nakazato, Y; Okazaki, S; Sumiyoshi, M; Suwa, S; Tanimoto, K; Yamagami, S; Yokoyama, K; Yokoyama, T1
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H1
Hoshino, C; Kikuchi, A; Kuriyama, C; Ohta, M; Sato, N; Sugawara, S1
Ishizaka, T; Iwasaki, H; Kise, H; Mitsumori, Y; Nakamura, Y; Sugiyama, A; Takahara, A1
Hirooka, Y; Sunagawa, K1
Araki, N; Ito, Y1
Furukawa, T; Kamegaya, E; Miyashita, Y; Nukada, T; Yoshii, M1
Dohi, Y; Kimura, G; Miyagawa, K; Nakazawa, A; Sato, K; Sugiura, T; Yamashita, S1
Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sato, E; Sugaya, T; Ueda, Y; Yamada, S; Yamagishi, S1
Bianchetti, MG; Fossali, EF; Milani, G; Ragazzi, M; Ramelli, GP; Rizzi, M; Simonetti, GD1
Futenma, A; Imai, H; Kimura, Y; Maeda, K; Miura, N; Suga, N; Yamada, H1
Aiba, N; Hara, M; Izumi, T; Kutsuna, T; Masuda, T; Matsumoto, T; Moriya, T; Noda, C; Ogura, MN; Takahira, N1
Asanuma, K; Fan, YY; Fujita, T; Hitomi, H; Kobori, H; Kohno, M; Nakano, D; Nishiyama, A; Noma, T; Ohashi, N; Ohsaki, H; Suwarni, D; Tomino, Y1
Kitakaze, M; Liao, YL; Luo, Q; Xi, F; Xuan, WL1
Friis, S; Olsen, JH; Qian, L; Rhodes, SL; Ritz, B; Schernhammer, E1
Jin, D; Miyazaki, M; Sakonjo, H; Takai, S1
Inada, H; Ishimitsu, T; Matsuoka, H; Nakano, N; Ohba, S; Okamura, A; Takahashi, T1
Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Nakamura, H; Wakahara, S1
Fukumoto, Y; Inoue, Y; Minatoguchi, S; Nishigaki, K; Shimokawa, H; Sueda, S; Urata, H; Yamanouchi, Y; Yasuda, S1
Kawano, Y; Matsuoka, H; Miwa, Y; Ohta, Y; Sasaguri, T; Tominaga, M; Tsuchihashi, T; Ueno, M1
Aritomi, S; Koganei, H; Konda, T; Mitsui, A; Nitta, K; Ogawa, T; Wagatsuma, H1
Laurent, S; Richy, FF1
Cao, B; Jia, S; Li, H; Lin, Y; Qu, P; Wang, M; Wu, F; Zhao, X1
Ceron, CS; Gerlach, RF; Guimaraes, DA; Marçal, DM; Martins-Oliveira, A; Rizzi, E; Tanus-Santos, JE1
Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M1
Comi-Diaz, C; Macias-Batista, A; Martinez-Martin, FJ; Pedrianes-Martin, P; Rodriguez-Rosas, H; Soriano-Perera, P1
Inagaki, K; Kumagai, I; Makino, H; Miyoshi, T; Nakamura, E; Ogura, T; Otsuka, F; Suzuki, J; Tanabe, K; Tsukamoto, N1
Kobara, M; Kojima, Y; Nakano, A; Nakata, T; Noda, K; Oshima, Y; Toba, H; Tojo, C; Wang, J; Yoshida, M1
Sansanayudh, N; Veerayuthvilai, S; Wongwiwatthananukit, S1
Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T2
Albayrak, F; Altunkaynak, ZB; Bayram, E; Beyzagül, P; Dursun, H; Halici, Z; Keleş, NO; Okçu, N; Süleyman, H; Ünal, B; Uyanik, A1
Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sato, E; Takeuchi, M; Ueda, Y; Yamagishi, S1
Daida, H; Fujiwara, Y; Hiro, T; Inoue, K; Kawamura, M; Kojima, T; Komiyama, N; Kurata, T; Miyauchi, K; Nakazato, Y; Okazaki, S; Sumiyoshi, M; Suwa, S; Tamura, H; Tanimoto, K; Yamagami, S; Yokoyama, K; Yokoyama, T1
Ichihara, K; Kano, S; Komatsu, K; Satoh, K1
Ando, K; Fujita, T; Haneda, M; Ito, S; Kashihara, N; Kishimoto, J; Nangaku, M; Node, K; Shimosawa, T1
Ando, K; Babazono, T; Fujita, T; Kario, K; Matsuoka, H; Nakao, K; Tanaka, S; Ueshima, K1
Kaneda, H; Ma, J; Morita, T1
Saito, Y; Takami, T2
Koriyama, H; Kyutoku, M; Mariana, OK; Morishita, R; Nakagami, F; Nakagami, H; Rakugi, H; Shimamura, M; Shimizu, H; Yasumasa, N1
Barsys, V; Duburs, G; Garaliene, V; Jakuska, P; Krauze, A1
Daida, H; Fukao, K; Hiki, M; Hirose, K; Kiyanagi, T; Kume, A; Kurata, T; Matsumori, R; Miyazaki, T; Ohsaka, H; Shimada, K1
Aladejebi, O; Hockerman, GH; Lin, M1
Fujimoto, S; Kashihara, N; Nagasu, H; Sasaki, T; Satoh, M; Tomita, N1
Shinozaki, K1
Chen, GL; Fan, CM; Li, HM; Li, YS; Lin, YZ; Pang, HM; Wang, L; Wu, SY; Yan, LR; Yu, J; Zhao, RP1
Fan, HQ; Li, Y; Wang, JG; Zou, J1
Arakawa, K; Jinnouchi, H; Jinnouchi, T; Kim-Mitsuyama, S; Matsui, K; Ogawa, H2
Inoue, T; Kikuta, T; Kojima, E; Nodaira, Y; Ohno, Y; Okayama, M; Seto, T; Sueyoshi, K; Suzuki, H; Takane, H; Takenaka, T; Watanabe, Y1
Hamada, T; Hasegawa, A; Hisatome, I; Ishida, K; Kato, M; Mishima, M; Miyazaki, S; Mizuta, E; Ninomiya, H; Nosaka, Y; Ogino, K; Ohtahara, A; Osaki, T; Sakata, S; Taniguchi, S; Watanabe, A; Yamada, K; Yamamoto, K; Yoshida, A1
Daikuhara, H; Ishida, T; Kikuchi, F1
Fujita, M; Ikai, A; Mitani, S; Miyamoto, S; Ogura, C; Ono, K; Sugimoto, N; Tanaka, S1
Kawano, K; Kitani, M; Koshiba, K; Kusunose, K; Orino, S; Sata, M; Soeki, T; Taketani, Y; Wakatsuki, T; Yagi, S1
Aritomi, S; Hattori, T; Ito, H; Kato, M; Murase, T; Murohara, T; Nagata, K; Nakashima, C; Nashima, K; Niinuma, K; Ohtake, M; Takahashi, K; Takatsu, M1
Barsys, V; Benetis, R; Garaliene, V; Jakuška, P1
Rich, MW1
Abe, M; Inoshita, A; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y1
Daida, H; Miyauchi, K1
Alberici, M; Ott, C; Raff, U; Ritt, M; Schmieder, RE; Schneider, MP; Striepe, K1
Fujisawa, M; Koike, H; Matsuoka, Y; Ueno, K; Yorikane, R1
Hiromura, K; Ikeuchi, H; Maeshima, A; Mishima, K; Miya, M; Nojima, Y; Sakurai, N1
Aritomi, S; Harada, E; Hirano, K; Ishikawa, T; Kim-Mitsuyama, S; Kuwahara, K; Mori, Y; Nishida, M; Saiki, S; Sunggip, C1
Iribe, G; Ito, H; Kaihara, K; Naruse, K1
Ando, K; Fujita, T; Kosugi, S; Matsuoka, H; Nakao, K; Sato, T; Tanaka, S; Ueshima, K1
Burnier, M1
Barsys, V; Benetis, R; Garaliene, V; Giedraitis, S; Krauze, A1
Ikeda, U; Izawa, A; Koyama, J; Miyashita, Y; Motoki, H; Takahashi, M; Tomita, T1
Furusho, H; Hamaoka, T; Ikeda, T; Inomata, J; Kaneko, S; Kobayashi, D; Murai, H; Sugiyama, Y; Takamura, M; Takata, S; Usui, S1
Ando, K; Fujita, T; Isshiki, M; Kashihara, N; Nakanishi, T; Nangaku, M; Nishizawa, Y; Nitta, K; Rakugi, H; Shimosawa, T; Takahashi, K; Tomita, K; Yokoyama, H1
Grassi, G1
Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H1
Harada, E; Hattori, T; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Niinuma, K; Takahashi, K; Takatsu, M; Watanabe, S1
Fujita, M; Hikita, T; Itakura, H; Ito, K; Ito, T; Mizuno, S; Mochizuki, K; Morita, T; Nakai, K; Ohno, Y; Saito, T; Shin, I; Soma, M; Sugawara, M; Takahashi, M; Takahashi, Y; Uchida, S1
Bernard, E; Bertrand, Y; Bleyzac, N; Goutelle, S1
Javeri, Y; Juneja, D; Nasa, P; Singh, A; Singh, O1
Cao, TS; Huynh, VM; Tran, VH1
Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A1
Hano, T; Iwane, N; Kawabe, T; Koike, Y; Nishihara, K2
Albayrak, A; Ayan, AK; Aydin, A; Bayir, Y; Cadirci, E; Demirci, E; Halici, Z; Karakus, E; Ozturk-Karagoz, B; Sahin, A; Unal, D1
Asai, S; Nakayama, T; Nishida, Y; Susa, N; Takahashi, Y; Yada, Y1
Eguchi, A; Fujiwara, S; Hirotani, S; Komamura, K; Koshiba, M; Mano, T; Masaki, M; Masuyama, T; Sugahara, M; Tsujino, T1
Bisenieks, E; Duburs, G; Gall Troselj, K; Krauze, A; Poikans, J; Velena, A; Zarkovic, N1
Brajković, G; Djordjević, S; Jović-Stosić, J; Mladenov, M; Putić, V; Zivanović, D1
Martinez-Martin, FJ; Saiz Satjes, M1
Fujii, M; Ichikawa, M; Imagawa, M; Ishizuka, T; Kaeriyama, S; Konoshita, T; Makino, Y; Nakamura, H; Nakaya, T; Sato, S; Suzuki, J; Urabe, M; Wakahara, S; Yamada, M; Yamamoto, K; Zenimaru, Y1
Catterall, WA; Gamal El-Din, TM; Pryde, DC; Scheuer, T; Swanson, TM; Tang, L; Zheng, N1
Shete, MM1
Calvo, C; Espinel, E; Esteban, R; Macias, JF; Mateos, L; Robles, NR; Sobrino, J1
Dimitriadis, K; Mani, I; Mantzouranis, E; Tousoulis, D; Tsioufis, C; Tsioufis, K1
Martinez-Martin, FJ; Roca-Cusachs, A; Saiz-Satjes, M1
de Vries, C; Haerden, Y; Lins, R1
Fendrikova, AV; Pyhalova, NE; Sirotenko, DV; Skibitsky, VV1
Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH1
Cha, BS; Chung, CH; Hwang, YC; Jang, HC; Lee, KW; Lee, MK; Min, KW; Yoon, KH1
Amari, Y; Ando, T; Ichihara, A; Iida, T; Morimoto, S1
Asayama, K; Hanazawa, T; Hosaka, M; Imai, Y; Inoue, R; Obara, T; Ohkubo, T; Satoh, M; Watabe, D1
Akasaka, H; Hongyo, K; Ito, N; Nozato, S; Nozato, Y; Rakugi, H; Sugimoto, K; Takami, Y; Takeda, M; Takeya, M; Takeya, Y; Yamamoto, K1
Canbolat, S; Nurullahoglu Atalik, KE1
Arima, H; Chaugai, S; Kerman, SRJ; Sepehry, AA; Sherpa, LY1
Jeon, SY; Lee, NR; Yim, CY1
Okamura, K; Shirai, K; Takamiya, Y; Urata, H; Yano, Y1
Kario, K; Kurose, Y; Matsuda, S; Nagahama, S; Sugii, H; Suzuki, N; Teshima, T2
Kobara, M; Nakata, T; Naseratun, N; Toba, H; Watanabe, Y1
Abdelsattar, AT; Alamodi, AA; Masoud, AT; Mohammed, OM; Nso, N; Payton, M; Shareef, MA; Sofy, AA1
Gao, S; Yan, N1
Ganesan, K; Panneerpandian, P; Rao, DB1
D, DC; Jj, NK; Kavitha, R1
Kafle, RC; Maskey, A; Sapkota, S1
Furui, M; Inagaki, K; Kamei, H; Matsubara, T1
Hojnacki, D; Podolsky, R; Schaller, B; Sternberg, Z; Tian, M; Yu, J1
Maiti, R; Maji, S; Pal, D1
Alsanosi, S; Bird, GS; D'Agostin, D; Lip, S; Padmanabhan, S; Parekh, AB1

Reviews

16 review(s) available for amlodipine and dihydropyridines

ArticleYear
New drugs for hypertension--variations on old themes.
    Drug and therapeutics bulletin, 1991, Mar-18, Volume: 29, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Delayed-Action Preparations; Dihydropyridines; Doxazosin; Humans; Hypertension; Isradipine; Nifedipine; Prazosin; Verapamil

1991
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
    European heart journal, 2000, Volume: 21, Issue:1

    Topics: Amlodipine; Calcium Channel Blockers; Diabetic Angiopathies; Dihydropyridines; Enalapril; Fosinopril; Humans; Hypertension; Randomized Controlled Trials as Topic

2000
Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
    American heart journal, 2000, Volume: 139, Issue:2 Pt 1

    Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Exercise Test; Exercise Tolerance; Felodipine; Heart Failure; Hemodynamics; Humans; Ventricular Function, Left

2000
Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
    Cardiovascular drug reviews, 2001,Spring, Volume: 19, Issue:1

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Drug Synergism; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Myocardial Contraction; Nitric Oxide; Vasodilation; Vasodilator Agents

2001
[Novel actions of calcium channel blockers].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 6

    Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Depression; Dihydropyridines; Evidence-Based Medicine; Heart Rate; Humans; Hypertension; Kidney Diseases; Proteinuria; Sympathetic Nervous System

2006
[Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and autonomic nervous system].
    Clinical calcium, 2010, Volume: 20, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Antioxidants; Autonomic Nervous System; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Humans

2010
[Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists].
    Clinical calcium, 2010, Volume: 20, Issue:1

    Topics: Amlodipine; Animals; Brain Edema; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cell Death; Cerebral Infarction; Dihydropyridines; Hippocampus; Humans; Neurons; Neuroprotective Agents; omega-Conotoxins; Rats

2010
Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:9

    Topics: Amlodipine; Angina Pectoris; Asian People; Calcium Channel Blockers; Coronary Vasospasm; Dihydropyridines; Diltiazem; Humans; Nifedipine; Prognosis; Treatment Outcome

2010
Efficacy and safety profiles of manidipine compared with amlodipine: a meta-analysis of head-to-head trials.
    Blood pressure, 2011, Volume: 20, Issue:1

    Topics: Adult; Amlodipine; Ankle; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Edema; Humans; Hypertension; Meta-Analysis as Topic; Nitrobenzenes; Piperazines; Publication Bias; Randomized Controlled Trials as Topic; Treatment Outcome

2011
Renal protection with calcium antagonists: the role of lercanidipine.
    Current medical research and opinion, 2013, Volume: 29, Issue:12

    Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; PubMed

2013
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative Stress.
    Oxidative medicine and cellular longevity, 2016, Volume: 2016

    Topics: Amlodipine; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cattle; Dihydropyridines; Epithelial Cells; Humans; Hydrogen; Lipoproteins, LDL; Mice; Microsomes; Mitochondria; Niacinamide; Nifedipine; Nitrobenzenes; Oxidants; Oxidative Stress; Piperazines

2016
Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine.
    Future cardiology, 2016, Volume: 12, Issue:4

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Nitrobenzenes; Piperazines

2016
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome

2018
Amlodipine Compared with Benidipine in the Management of Hypertension: A Systematic Review and Meta-Analysis.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2020, Volume: 27, Issue:6

    Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome; Vasodilator Agents

2020
Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023, Volume: 30, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension

2023
A Reappraisal of the Effects of L-type Ca
    Function (Oxford, England), 2023, Volume: 4, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Dihydropyridines; Fura-2; Heart Failure; Humans; Hypertension; Prospective Studies

2023

Trials

82 trial(s) available for amlodipine and dihydropyridines

ArticleYear
Efficacy and safety evaluation of lacidipine compared with amlodipine in mild-to-moderate hypertensive patients.
    Journal of cardiovascular pharmacology, 1994, Volume: 23 Suppl 5

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged

1994
Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:2

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Female; Half-Life; Humans; Hypertension; Male; Middle Aged; Pulse

1996
Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:6

    Topics: Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Reference Values; Renin; Sympathetic Nervous System

1999
Amlodipine and physiological responses to brisk exercise in healthy subjects.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:6

    Topics: Adult; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Exercise; Hemodynamics; Hormones; Humans; Male; Time Factors

1999
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
    Journal of hypertension, 2000, Volume: 18, Issue:12

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Norepinephrine; Piperazines; Sympathetic Nervous System

2000
Effect of calcium antagonists on stress-induced rise in blood pressure and heart rate: a double-blind, placebo-controlled study.
    International journal of clinical pharmacology and therapeutics, 2001, Volume: 39, Issue:1

    Topics: Adult; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cold Temperature; Dihydropyridines; Double-Blind Method; Exercise; Hand Strength; Heart Rate; Humans; Stress, Psychological

2001
Ankle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:3 Suppl 1

    Topics: Adolescent; Adult; Aged; Amlodipine; Ankle; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Edema; Female; Foot; Humans; Hypertension; Joint Diseases; Male; Middle Aged; Single-Blind Method

2000
Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:4

    Topics: Adult; Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Chi-Square Distribution; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Quality of Life; Statistics, Nonparametric

2001
The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
    American journal of hypertension, 2001, Volume: 14, Issue:11 Pt 1

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Autonomic Nervous System; Baroreflex; Blood Pressure; Calcium Channel Blockers; Carrier Proteins; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Steroid Isomerases; Treatment Outcome; Verapamil

2001
Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:6

    Topics: Amlodipine; beta-Thromboglobulin; Blood Pressure; Calcium Channel Blockers; Cold Temperature; Cross-Over Studies; Dihydropyridines; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Platelet Activation; Stress, Physiological; Sympathetic Nervous System

2001
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
    Journal of human hypertension, 2002, Volume: 16, Issue:3

    Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Apoprotein(a); Benzazepines; Calcium Channel Blockers; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Lipoprotein(a); Male; Middle Aged; Pilot Projects; Triglycerides

2002
Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.
    American journal of hypertension, 2002, Volume: 15, Issue:11

    Topics: Aged; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Peripheral Vascular Diseases; Treatment Outcome

2002
Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physicians' Offices

2003
Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine.
    Journal of hypertension, 2003, Volume: 21, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diastole; Dihydropyridines; Drug Evaluation; Edema; Female; Heart Rate; Humans; Hypertension; Leg; Middle Aged; Norway; Postmenopause; Statistics as Topic; Systole; Time Factors; Treatment Outcome; Women's Health

2003
Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients.
    Journal of hypertension, 2003, Volume: 21, Issue:10

    Topics: Adult; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Edema; Humans; Hypertension; Laser-Doppler Flowmetry; Leg; Male; Middle Aged; Skin; Treatment Outcome; Vasoconstriction

2003
Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2003, Volume: 25, Issue:8

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine

2003
Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:6

    Topics: Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, N-Type; Creatinine; Dihydropyridines; Female; Humans; Hypertension, Renal; Logistic Models; Male; Middle Aged; Proteinuria; Treatment Outcome

2004
Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:7

    Topics: Aged; Amlodipine; Analysis of Variance; Body Mass Index; Calcium Channel Blockers; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Obesity; Piperazines; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

2004
Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    International journal of cardiology, 2005, Jun-08, Volume: 101, Issue:3

    Topics: Adult; Aged; Amlodipine; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Male; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left

2005
Effect of amlodipine and lacidipine on left ventricular diastolic and long axis functions in arterial hypertension and stable angina pectoris.
    Acta cardiologica, 2005, Volume: 60, Issue:3

    Topics: Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Diastole; Dihydropyridines; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Mitral Valve; Ultrasonography, Doppler; Ventricular Function, Left

2005
Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:12

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged

2005
The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2006, Volume: 22

    Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Creatinine; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Sympathetic Nervous System; Urine

2006
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
    Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:10

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Secondary Prevention; Tetrazoles

2006
Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:10

    Topics: Aged; Amlodipine; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Physicians' Offices

2006
Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.
    The American journal of the medical sciences, 2007, Volume: 333, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Amlodipine; Antioxidants; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Dihydropyridines; Fatty Acid-Binding Proteins; Female; Heart Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria

2007
Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Azetidinecarboxylic Acid; Baroreflex; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies

2007
Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Clinical drug investigation, 2007, Volume: 27, Issue:9

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chlorthalidone; Dihydropyridines; Diuretics; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Risk Assessment; Risk Factors; Systole; Time Factors; Treatment Outcome

2007
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:7

    Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Cross-Over Studies; Dihydropyridines; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria

2007
Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Journal of hypertension, 2007, Volume: 25, Issue:10

    Topics: Albuminuria; Amlodipine; Antihypertensive Agents; Arteries; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Safety; Vasodilation

2007
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressure.
    Endocrine journal, 2007, Volume: 54, Issue:5

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Ascorbic Acid; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Erythrocytes; Female; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged; Organophosphorus Compounds; Pyrenes; Vitamin E

2007
Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:8

    Topics: Aged; Aged, 80 and over; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Norepinephrine; Organophosphorus Compounds

2007
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
    Kidney international, 2007, Volume: 72, Issue:12

    Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension, Renal; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Renin-Angiotensin System; Treatment Outcome

2007
Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:9

    Topics: Aged; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Female; Guideline Adherence; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Proteinuria; Pulse; Renin-Angiotensin System

2007
High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study.
    International journal of clinical practice, 2008, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cross-Sectional Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Nifedipine

2008
Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Cardiovascular therapeutics, 2008,Spring, Volume: 26, Issue:1

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Sectional Studies; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Logistic Models; Male; Middle Aged; Nifedipine; Primary Health Care; Spain; Vasodilation

2008
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Expert review of cardiovascular therapy, 2008, Volume: 6, Issue:10

    Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Renin-Angiotensin System

2008
Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:4

    Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Protective Agents; Proteinuria

2009
Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:8

    Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Organophosphorus Compounds; Renin; Time Factors

2009
Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:7

    Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Single-Blind Method; Tumor Necrosis Factor-alpha

2009
Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:16

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cerebrovascular Disorders; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged

2009
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Journal of atherosclerosis and thrombosis, 2009, Volume: 16, Issue:5

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aldosterone; Amlodipine; Arteries; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Glycated Hemoglobin; Humans; Hypertension; Kidney; Lipids; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds

2009
Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J).
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:5

    Topics: Adult; Aged; Amlodipine; Azetidinecarboxylic Acid; Calcium Channel Blockers; Coronary Artery Disease; Dihydropyridines; Disease Progression; Double-Blind Method; Endpoint Determination; Female; Humans; Hypertension; Male; Middle Aged; Ultrasonography; Young Adult

2009
Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Renal Insufficiency, Chronic; Tetrazoles

2010
Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease.
    The American journal of the medical sciences, 2010, Volume: 339, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Amlodipine; Atherosclerosis; Biomarkers; Calcium Channel Blockers; Deoxyguanosine; Dihydropyridines; Fatty Acid-Binding Proteins; Female; Humans; Inflammation; Kidney Failure, Chronic; Male; Proteinuria

2010
Superior palatability of crushed lercanidipine compared with amlodipine among children.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:2

    Topics: Administration, Oral; Amlodipine; Calcium Channel Blockers; Child; Child, Preschool; Dihydropyridines; Female; Humans; Kidney Diseases; Male; Patient Compliance; Patient Satisfaction; Single-Blind Method; Smell; Statistics as Topic; Taste

2010
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
    International heart journal, 2010, Volume: 51, Issue:3

    Topics: Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cross-Over Studies; Dihydropyridines; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Renal Dialysis; Renin-Angiotensin System

2010
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
    Journal of hypertension, 2010, Volume: 28, Issue:10

    Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin I; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System

2010
Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:6

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Japan; Male; Proteinuria; Treatment Outcome

2010
Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure Monitoring, Ambulatory; China; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome

2010
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:2

    Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Diabetic Nephropathies; Dihydropyridines; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Hypertension; Male; Middle Aged; Nephrosclerosis; Potassium; Severity of Illness Index; Sodium

2011
Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
    Clinical drug investigation, 2011, Volume: 31, Issue:3

    Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Insulin Resistance; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Spain; Telmisartan

2011
Comparison of changes of body water measured by using bioelectrical impedance analysis between lercanidipine and amlodipine therapy in hypertensive outpatients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010, Volume: 93 Suppl 6

    Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Body Composition; Body Water; Dihydropyridines; Edema; Electric Impedance; Extracellular Fluid; Female; Humans; Hypertension; Intracellular Fluid; Male; Middle Aged; Outpatients; Prospective Studies; Thailand; Treatment Outcome

2010
Calcium channel blocker inhibition of AGE and RAGE axis limits renal injury in nondiabetic patients with stage I or II chronic kidney disease.
    Clinical cardiology, 2011, Volume: 34, Issue:6

    Topics: Adult; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Calcium Channel Blockers; Chronic Disease; Dihydropyridines; Female; Glycation End Products, Advanced; Humans; Hypertension; Japan; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Time Factors; Treatment Outcome

2011
Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J).
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:5

    Topics: Amlodipine; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Dihydropyridines; Humans; Hypertension; Lipids; Plaque, Atherosclerotic; Ultrasonography, Interventional

2011
Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action
    Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:4

    Topics: Adult; Aged; Albuminuria; Amlodipine; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diabetic Nephropathies; Dihydropyridines; Drug Therapy, Combination; Humans; Hypertension; Imidazoles; Middle Aged; Research Design; Sympatholytics; Tetrazoles

2011
Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:7

    Topics: Aged; Albuminuria; Amlodipine; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Renin-Angiotensin System

2011
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study.
    Vascular health and risk management, 2011, Volume: 7

    Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography

2011
Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endotheli
    Cardiovascular diabetology, 2011, Sep-10, Volume: 10

    Topics: Adult; Aged; Amlodipine; Azetidinecarboxylic Acid; Blood Glucose; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Prospective Studies; Stem Cells

2011
Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:1

    Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Tablets, Enteric-Coated

2012
Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Single-Blind Method; Survival Analysis; Tetrazoles; Treatment Outcome

2012
Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney disease: a randomized controlled study.
    American journal of nephrology, 2012, Volume: 35, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Time

2012
The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study.
    Diabetes & vascular disease research, 2012, Volume: 9, Issue:4

    Topics: Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Chi-Square Distribution; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Therapy, Combination; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Tetrazoles; Time Factors; Treatment Outcome

2012
L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Blood pressure, 2012, Volume: 21, Issue:6

    Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cross-Over Studies; Dihydropyridines; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Hypertension; Male; Nitrophenols; Norepinephrine; Organophosphorus Compounds; Prospective Studies; Sympathetic Nervous System

2012
Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:11

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Antioxidants; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Dihydropyridines; Fatty Acid-Binding Proteins; Female; Heart Rate; Humans; Hypertension; Incidence; Male; Middle Aged; Oxidative Stress; Prospective Studies; Renal Insufficiency, Chronic

2012
L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.
    Heart and vessels, 2013, Volume: 28, Issue:4

    Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Creatinine; Dihydropyridines; Down-Regulation; Fatty Acid-Binding Proteins; Female; Humans; Hypertension; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome

2013
[Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo Medical University].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Oct-10, Volume: 101, Issue:10

    Topics: Aged; Amlodipine; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Dihydropyridines; Female; Humans; Hypertension; Male; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Preoperative Period; Prospective Studies; Ultrasonography, Interventional

2012
Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension.
    British journal of clinical pharmacology, 2013, Volume: 75, Issue:1

    Topics: Adult; Aged; Albuminuria; Amlodipine; Creatinine; Dihydropyridines; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Nitrobenzenes; Piperazines

2013
Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Aged; Amlodipine; Azetidinecarboxylic Acid; Diastole; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Pulse Wave Analysis; Tetrazoles; Vascular Stiffness; Ventricular Function, Left

2013
Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    International journal of medical sciences, 2013, Volume: 10, Issue:9

    Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System

2013
Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Asian People; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Japan; Male; Prospective Studies; Risk Factors; Sex Factors; Tetrazoles; Treatment Outcome

2014
Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.
    Echocardiography (Mount Kisco, N.Y.), 2014, Volume: 31, Issue:10

    Topics: Adult; Aged; Amlodipine; Analysis of Variance; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler, Pulsed; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Image Interpretation, Computer-Assisted; Male; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling

2014
Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
    Journal of hypertension, 2014, Volume: 32, Issue:9

    Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Baroreflex; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Essential Hypertension; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Sympathetic Nervous System

2014
Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics Tr
    International journal of medical sciences, 2014, Volume: 11, Issue:9

    Topics: Adult; Aged; Albuminuria; Amlodipine; Blood Pressure; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Renin-Angiotensin System

2014
Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study).
    Journal of clinical hypertension (Greenwich, Conn.), 2014, Volume: 16, Issue:10

    Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Blood Pressure; Calcium Channel Blockers; Creatinine; Cross-Over Studies; Diabetic Nephropathies; Dihydropyridines; Dose-Response Relationship, Drug; Drug Substitution; Female; Humans; Hypertension, Renal; Japan; Kidney Failure, Chronic; Male; Middle Aged; Nephrosclerosis; Uric Acid

2014
Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
    Current medical research and opinion, 2015, Volume: 31, Issue:1

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Brain Ischemia; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Stroke; Treatment Outcome

2015
Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Heart and vessels, 2016, Volume: 31, Issue:11

    Topics: Amlodipine; Atrial Function, Left; Atrial Remodeling; Biomarkers; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; China; Diastole; Dihydropyridines; Down-Regulation; Echocardiography, Doppler; Female; Humans; Hypertension; Hyperuricemia; Male; Middle Aged; Time Factors; Treatment Outcome; Uric Acid; Ventricular Dysfunction, Left; Ventricular Function, Left

2016
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.
    Current medical research and opinion, 2016, Volume: 32, Issue:sup2

    Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies

2016
Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
    Current medical research and opinion, 2016, Volume: 32, Issue:sup2

    Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Sympathetic Nervous System; Vascular Stiffness

2016
Factors associated with the reduction of albumin excretion in diabetic hypertensive patients: differential effect of manidipine versus amlodipine.
    Future cardiology, 2017, Volume: 13, Issue:2

    Topics: Adult; Aged; Albumins; Albuminuria; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Nitrobenzenes; Piperazines

2017
Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial.
    International journal of clinical practice, 2017, Volume: 71, Issue:9

    Topics: Adult; Aged; Albuminuria; Amlodipine; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome

2017
Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:5

    Topics: Aged; Albuminuria; Amlodipine; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Irbesartan; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Tetrazoles; Trichlormethiazide; Urinalysis

2018
A Randomized Open-Label Parallel-Group Study Comparing the Efficacy and Safety of Cilnidipine and Amlodipine in Hypertensive Adults.
    The Journal of the Association of Physicians of India, 2022, Volume: 69, Issue:12

    Topics: Adult; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; India

2022

Other Studies

137 other study(ies) available for amlodipine and dihydropyridines

ArticleYear
[Amlodipine: pharmacokinetic and pharmacodynamic profile of a calcium antagonist with prolonged effect].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1992, Feb-11, Volume: 81, Issue:7

    Topics: Amlodipine; Angina Pectoris; Animals; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Humans; Nifedipine; Structure-Activity Relationship

1992
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
    Molecular pharmacology, 1992, Volume: 41, Issue:2

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil

1992
Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium.
    The Journal of general physiology, 1991, Volume: 98, Issue:1

    Topics: Amlodipine; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Chemical Phenomena; Chemistry, Physical; Diffusion; Dihydropyridines; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Myocardium; Nifedipine; Nisoldipine; Receptors, Nicotinic

1991
A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1990, Volume: 17, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Brain; Cholesterol; Dihydropyridines; Gels; Lipid Bilayers; Membranes; Models, Chemical; Models, Molecular; Myocardium; Nifedipine; Rats; Receptors, Drug; Sarcolemma; Solubility

1990
The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
    Brain research bulletin, 1990, Volume: 25, Issue:1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Male; Mice; Nifedipine; Nimodipine; Seizures

1990
The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:3

    Topics: Amlodipine; Anesthesia; Animals; Blood Gas Analysis; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Nifedipine; Nitrendipine; Stroke Volume; Vascular Resistance; Verapamil

1991
Biotransformation of amlodipine. Identification and synthesis of metabolites found in rat, dog and human urine/confirmation of structures by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:2

    Topics: Amlodipine; Animals; Biotransformation; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dihydropyridines; Dogs; Gas Chromatography-Mass Spectrometry; Humans; Nifedipine; Rats; Species Specificity

1989
Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    The American journal of cardiology, 1989, Nov-07, Volume: 64, Issue:17

    Topics: Amlodipine; Animals; Antihypertensive Agents; Arteriosclerosis; Calcium; Calcium Channel Blockers; Dihydropyridines; Heart; In Vitro Techniques; Isoproterenol; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Rabbits; Rats; Retinal Artery; Swine; Vasoconstriction

1989
Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery.
    The American journal of cardiology, 1989, Nov-07, Volume: 64, Issue:17

    Topics: Amlodipine; Animals; Binding Sites; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Isradipine; Nifedipine; Oxadiazoles; Potassium Chloride; Sarcolemma; Stereoisomerism; Swine; Vasoconstriction; Vasodilation

1989
Modulation of calcium channels by charged and neutral dihydropyridines.
    Annals of the New York Academy of Sciences, 1989, Volume: 560

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electric Conductivity; Electrochemistry; Hydrogen-Ion Concentration; Ions; Membrane Potentials; Nifedipine; Protons

1989
Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:9

    Topics: Amlodipine; Animals; Biological Assay; Biological Availability; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; Guinea Pigs; Hemodynamics; Kinetics; Male; Nifedipine; Pyridines; Rats; Vasoconstriction

1986
Residual inhibition in density of [3H]isradipine binding sites in rat brain membrane pretreated with amlodipine.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1995, Volume: 16, Issue:4

    Topics: Amlodipine; Animals; Binding Sites; Brain; Calcium Channel Blockers; Dihydropyridines; Isradipine; Male; Nifedipine; Oxadiazoles; Radioligand Assay; Rats; Rats, Wistar

1995
Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs.
    Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:11

    Topics: Amlodipine; Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; Electric Stimulation; Female; Heart; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Papillary Muscles

1994
Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro.
    Pharmacology & toxicology, 1995, Volume: 76, Issue:1

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Felodipine; Heart; Heart Rate; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nifedipine; Organ Specificity; Rats; Rats, Inbred SHR

1995
Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:1

    Topics: Amlodipine; Animals; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Guinea Pigs; Heart Ventricles; Humans; Isradipine; Kinetics; Membrane Potentials; Muscle, Skeletal; Myocardium; Rabbits

1995
Vascular reactivity: a measurement of calcium channel blockade.
    Journal of human hypertension, 1995, Volume: 9 Suppl 1

    Topics: Amlodipine; Angiotensin II; Blood Pressure; Dihydropyridines; Humans; Infusions, Intravenous; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Vasoconstriction

1995
Probing membrane bilayer interactions of 1,4-dihydropyridine calcium channel blockers. Implications for aging and Alzheimer's disease.
    Annals of the New York Academy of Sciences, 1994, Dec-15, Volume: 747

    Topics: Aged; Aging; Alzheimer Disease; Amlodipine; Brain Chemistry; Calcium Channel Blockers; Cell Membrane; Cholesterol; Dihydropyridines; Female; Humans; In Vitro Techniques; Lipid Bilayers; Male; Membrane Lipids; Membrane Proteins; Nerve Tissue Proteins; Neurons; Parkinson Disease; Phospholipids; Solubility; X-Ray Diffraction

1994
In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
    Biochemical and biophysical research communications, 1994, Sep-30, Volume: 203, Issue:3

    Topics: Adult; Amlodipine; Antioxidants; Calcium Channel Blockers; Copper; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; Isradipine; Lipoproteins, LDL; Oxidation-Reduction; Reference Values; Thiobarbituric Acid Reactive Substances; Verapamil; Vitamin E

1994
Quantification of the calcium antagonism of lacidipine by kinetic analysis.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

    Topics: Amlodipine; Animals; Binding Sites; Body Fluid Compartments; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Male; Mathematical Computing; Models, Biological; Muscle Proteins; Rabbits

1994
Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists.
    The American journal of cardiology, 1994, Jan-27, Volume: 73, Issue:3

    Topics: Amlodipine; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Electrophysiology; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Myocardial Contraction; Myocardial Ischemia; Ventricular Function, Left

1994
Ca2+ channel blocking activity of lacidipine and amlodipine in A7r5 vascular smooth muscle cells.
    European journal of pharmacology, 1993, Jan-15, Volume: 244, Issue:2

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Cytosol; Dihydropyridines; Female; Fura-2; Muscle, Smooth, Vascular; Nifedipine; Nitrendipine; Potassium Chloride; Pregnancy; Rats; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet

1993
Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:10

    Topics: Adrenergic beta-Antagonists; Amlodipine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Dihydropyridines; Diuretics; Felodipine; Fibroblasts; Furosemide; Gene Expression Regulation; Humans; Interleukin-6; Interleukin-8; Isradipine; Lung; Muscle Proteins; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Propranolol; Transcription, Genetic

1995
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, May-28, Volume: 93, Issue:11

    Topics: Amlodipine; Becaplermin; Calcium Channel Blockers; Cells, Cultured; Collagen; Collagenases; Dihydropyridines; Diltiazem; Enzyme Activation; Extracellular Matrix; Felodipine; Fibroblasts; Humans; Kinetics; Lung; Metalloendopeptidases; Muscle, Smooth, Vascular; Nitrobenzenes; Piperazines; Platelet-Derived Growth Factor; Procollagen; Proline; Proto-Oncogene Proteins c-sis; Transcription, Genetic; Verapamil

1996
Enantiomer separation of dihydropyridine calcium antagonists with cyclodextrins as chiral selectors: structural correlation.
    Journal of chromatography. B, Biomedical applications, 1996, May-31, Volume: 681, Issue:1

    Topics: Amlodipine; Buffers; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cyclodextrins; Dihydropyridines; Electrolytes; Electrophoresis, Capillary; Isradipine; Microspheres; Molecular Conformation; Nimodipine; Nisoldipine; Nitrendipine; Sodium Dodecyl Sulfate; Solvents; Stereoisomerism; Surface-Active Agents

1996
Effects of benidipine, a long-acting calcium antagonist, on renal functions in anaesthetized spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Amlodipine; Anesthesia; Animals; Calcium Channel Blockers; Dihydropyridines; Diuresis; Kidney; Kidney Function Tests; Lithium; Male; Natriuresis; Rats; Rats, Inbred SHR

1995
Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
    European journal of pharmacology, 1997, Apr-18, Volume: 324, Issue:2-3

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Injections, Intravenous; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Venous Pressure

1997
Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging.
    Bioorganic & medicinal chemistry, 1997, Volume: 5, Issue:4

    Topics: Amlodipine; Animals; Binding, Competitive; Calcium Channel Blockers; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dihydropyridines; Dogs; Heart; Heart Diseases; Isotope Labeling; Isradipine; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Myocardium; Reproducibility of Results; Stereoisomerism; Tomography, Emission-Computed

1997
Molecular pharmacology of UK-118, 434-05, a permanently charged amlodipine analog.
    International journal of cardiology, 1997, Dec-31, Volume: 62 Suppl 2

    Topics: Amlodipine; Binding Sites; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Gene Expression; Humans; Kidney; Membrane Potentials; Muscle, Smooth, Vascular; Myocardium; Structure-Activity Relationship

1997
Catalepsy induced by calcium channel blockers in mice.
    Biopharmaceutics & drug disposition, 1998, Volume: 19, Issue:2

    Topics: Amlodipine; Animals; Binding, Competitive; Calcium Channel Blockers; Catalepsy; Dihydropyridines; Diltiazem; Disease Models, Animal; Flunarizine; Male; Mice; Muscarinic Antagonists; Nitrobenzenes; Piperazines; Predictive Value of Tests; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine; Time Factors; Verapamil

1998
Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
    Molecular and cellular biochemistry, 1998, Volume: 178, Issue:1-2

    Topics: Amlodipine; Animals; Aorta; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dimethyl Sulfoxide; Dinoprost; Endothelium, Vascular; Indomethacin; Male; Methylene Blue; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents

1998
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Acetylcholine; Acridines; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Diet, Atherogenic; Dihydropyridines; Electron Spin Resonance Spectroscopy; Hypercholesterolemia; Lipids; Luminescent Measurements; Macrophages; Male; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Phenylephrine; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, LDL; Renin-Angiotensin System; Superoxides; Tetrazoles; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

1999
[Effects of benidipine hydrochloride (Coniel) on blood pressure, heart rate and plasma norepinephrine concentration in spontaneously hypertensive rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 113, Issue:5

    Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Hypertension; Male; Nifedipine; Norepinephrine; Rats; Rats, Inbred SHR

1999
Resolution of newly synthesized racemic dihydropyridines with different chiral selectors by means of capillary electrophoresis.
    Journal of chromatography. A, 1999, Aug-20, Volume: 853, Issue:1-2

    Topics: Amlodipine; Calcium Channel Blockers; Cyclodextrins; Dihydropyridines; Electrophoresis, Capillary; Nicardipine; Stereoisomerism

1999
Pranidipine enhances the action of nitric oxide released from endothelial cells.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 1

    Topics: Amlodipine; Animals; Aorta, Thoracic; Calcium Channel Blockers; Cells, Cultured; Coculture Techniques; Cyclic GMP; Dihydropyridines; Endothelin-1; Endothelium, Vascular; Humans; Hypertension; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Superoxide Dismutase

2000
Modulation of tumor necrosis factor-alpha production with anti-hypertensive drugs.
    Immunopharmacology, 2000, Volume: 48, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Diuretics; Doxazosin; Humans; Hydrochlorothiazide; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Metoprolol; Mice; Mice, Inbred BALB C; Monocytes; Nicardipine; Nitrobenzenes; Piperazines; Sodium Chloride Symporter Inhibitors; Tumor Necrosis Factor-alpha

2000
Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:6

    Topics: Amlodipine; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Drug Interactions; Ethosuximide; Female; Gallopamil; Humans; In Vitro Techniques; Isradipine; Male; Mibefradil; Myocardial Contraction; Perfusion; Radioligand Assay; Rats; Rats, Wistar; Ventricular Pressure

2000
Improvement in the histopathology of hearts from cardiomyopathic BIO TO-2 hamsters following long-term administration of amlodipine and cilnidipine.
    Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:10

    Topics: Amlodipine; Animals; Animals, Inbred Strains; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiomyopathies; Cricetinae; Dihydropyridines; Heart; Kinetics; Male; Mesocricetus; Myocardium; Organ Size

2000
Effects of long-term treatment with calcium antagonists on periarterial nerve function in the mesenteric artery of spontaneously hypertensive rats.
    Japanese journal of pharmacology, 2000, Volume: 84, Issue:2

    Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Hypertension; Male; Mesenteric Arteries; Nervous System; Nicardipine; Norepinephrine; Rats; Rats, Inbred SHR; Vasoconstrictor Agents; Vasodilator Agents

2000
Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries.
    British journal of pharmacology, 2001, Volume: 134, Issue:1

    Topics: Amlodipine; Angiotensin II; Arteries; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Flavonoids; Genistein; Humans; In Vitro Techniques; Nickel; Norepinephrine; Potassium; Ryanodine; Skin; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2001
Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.
    British journal of pharmacology, 2001, Volume: 134, Issue:7

    Topics: Actins; Amlodipine; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Collagen Type I; Dihydropyridines; Dose-Response Relationship, Drug; Fibrosis; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy; Kidney; Male; Muscle, Skeletal; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001
The use of cyclodextrin-modified capillary electrophoresis in the determination of the enantiomeric purity.
    Journal of capillary electrophoresis and microchip technology, 2002, Volume: 7, Issue:1-2

    Topics: Amlodipine; Cyclodextrins; Dihydropyridines; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Stereoisomerism

2002
In vivo receptor binding of benidipine and amlodipine in mesenteric arteries and other tissues of spontaneously hypertensive rats.
    Life sciences, 2002, Mar-15, Volume: 70, Issue:17

    Topics: Amlodipine; Animals; Area Under Curve; Blood Proteins; Calcium Channel Blockers; Calcium Channels, L-Type; Cerebral Cortex; Dihydropyridines; Drug Interactions; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Protein Binding; Rats; Rats, Inbred SHR; Tissue Distribution

2002
Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.
    British journal of clinical pharmacology, 2002, Volume: 54, Issue:3

    Topics: Adolescent; Adult; Amlodipine; Calcium Channel Blockers; Child; Child, Preschool; Cyclosporine; Dihydropyridines; Edema; Female; Flushing; Humans; Hypertension; Infant; Male

2002
Dihydropyridines are not substitutable without careful monitoring.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2002, Volume: 92, Issue:8

    Topics: Adverse Drug Reaction Reporting Systems; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Delayed-Action Preparations; Dihydropyridines; Felodipine; Humans; Nifedipine

2002
[Pharmaceutical chemistry of "dipines"].
    Acta pharmaceutica Hungarica, 2002, Volume: 72, Issue:3

    Topics: Amlodipine; Calcium Channel Blockers; Dihydropyridines; Molecular Structure; Nifedipine; Nimodipine; Structure-Activity Relationship

2002
Emerging data on calcium-channel blockers: the COHORT study.
    Clinical cardiology, 2003, Volume: 26, Issue:2 Suppl 2

    Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic

2003
Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 41, Issue:4

    Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Dihydropyridines; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Kinetics; Male; Mitogen-Activated Protein Kinases; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases, 70-kDa

2003
Antioxidant activity of different dihydropyridines.
    Biochemical and biophysical research communications, 2003, Mar-21, Volume: 302, Issue:4

    Topics: Amlodipine; Animals; Antioxidants; Cattle; Cells, Cultured; Dihydropyridines; Endothelium, Vascular; Fluoresceins; Humans; Lipoproteins, LDL; Molecular Structure; Nifedipine; Nimodipine; Reactive Oxygen Species

2003
Enantiomeric separation by HPLC of 1,4-dihydropyridines with vancomycin as chiral selector.
    Chirality, 2003, Volume: 15, Issue:6

    Topics: Amlodipine; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dihydropyridines; Models, Molecular; Molecular Conformation; Stereoisomerism; Vancomycin

2003
Protective effect of benidipine against sodium azide-induced cell death in cultured neonatal rat cardiac myocytes.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:2

    Topics: Adenosine Triphosphate; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cell Death; Cells, Cultured; Cysteine Proteinase Inhibitors; Dihydropyridines; Dipeptides; Dose-Response Relationship, Drug; In Vitro Techniques; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria, Muscle; Myocytes, Cardiac; Nifedipine; Rats; Rats, Sprague-Dawley; Sodium Azide; Tetrazoles

2003
Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties.
    Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:5

    Topics: Amlodipine; Antioxidants; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-8; Radioligand Assay; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Umbilical Veins

2004
Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:4

    Topics: Administration, Sublingual; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris, Variant; Calcium Channel Blockers; Cohort Studies; Diabetes Complications; Dihydropyridines; Female; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prognosis; Smoking; Survival Rate; Vasodilator Agents

2004
The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
    Nephron. Physiology, 2005, Volume: 101, Issue:1

    Topics: Amlodipine; Animals; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dietary Sucrose; Dihydropyridines; Disease Models, Animal; Hypertension, Renal; Kidney Diseases; Male; Metabolic Syndrome; Rats; Rats, Inbred Dahl; Treatment Outcome

2005
Increased vascular selectivity and prolonged pharmacological efficacy of the L-type Ca2+ channel antagonist lercanidipine in human cardiovascular tissue.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:9

    Topics: Adolescent; Adult; Aged; Amlodipine; Binding, Competitive; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Myocardial Contraction; Nifedipine; Protein Binding; Stimulation, Chemical; Vasodilation

2005
Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:8

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Aorta; Blood Pressure; Body Weight; Calcium Channel Blockers; Chemokine CCL2; Dihydropyridines; Enzyme Inhibitors; Gene Expression Regulation; Heart Rate; Hypertension; Inflammation; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Oxidative Stress; Peptidyl-Dipeptidase A; Piperazines; Polymerase Chain Reaction; Rats; Rats, Wistar; RNA, Messenger; Vascular Cell Adhesion Molecule-1

2005
Comparative effects of pranidipine with amlodipine in rats with heart failure.
    Pharmacology, 2006, Volume: 77, Issue:1

    Topics: Administration, Oral; Amlodipine; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Calcium-Transporting ATPases; Cardiac Myosins; Dihydropyridines; Dose-Response Relationship, Drug; Echocardiography; Fibrosis; Heart Failure; Heart Rate; Male; Myocarditis; Myocardium; Nitric Oxide Synthase Type II; Rats; Rats, Inbred Lew; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Survival Rate; Time Factors; Ventricular Function, Left

2006
Effects of a new calcium channel blocker, azelnidipine, on systemic hemodynamics and renal sympathetic nerve activity in spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:12

    Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Baroreflex; Calcium Channel Blockers; Dihydropyridines; Hemodynamics; Kidney; Male; Nitroprusside; Phenylephrine; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Vasoconstrictor Agents; Vasodilator Agents

2005
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.
    Journal of hypertension, 2006, Volume: 24, Issue:10

    Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Cardiomegaly; Dihydropyridines; Endomyocardial Fibrosis; Hydralazine; Hypertension; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tachycardia; Ventricular Remodeling

2006
Effects of benidipine, a long-lasting dihydropyridine-Ca2+ channel blocker, on cerebral blood flow autoregulation in spontaneously hypertensive rats.
    Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:11

    Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Calcium Channel Blockers; Carbon Dioxide; Cerebral Cortex; Dihydropyridines; Hypertension; Male; Oxygen; Rats; Rats, Inbred SHR; Rats, Wistar; Species Specificity; Tetrazoles; Ultrasonography, Doppler, Pulsed; Vascular Resistance

2006
Effects of benidipine in a rat model for experimental angina.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006, Volume: 126, Issue:12

    Topics: Amlodipine; Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Male; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred Strains

2006
G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
    Biochemical pharmacology, 2007, Apr-01, Volume: 73, Issue:7

    Topics: Amlodipine; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinases; Dihydropyridines; G1 Phase; Humans; Nuclear Proteins; Phosphorylation; Repressor Proteins; Tumor Cells, Cultured

2007
Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
    Brain research, 2007, Oct-24, Volume: 1176

    Topics: Amlodipine; Animals; Antioxidants; Apoptosis; Azetidinecarboxylic Acid; Brain; Brain Edema; Brain Infarction; Calcium Channel Blockers; Dihydropyridines; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Inbred WKY; Reperfusion Injury; Treatment Outcome

2007
Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats.
    European journal of pharmacology, 2008, Jan-28, Volume: 579, Issue:1-3

    Topics: Amlodipine; Animals; Bone and Bones; Calcium; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Femur; Osteoporosis; Ovariectomy; Phosphorus; Rats; Rats, Wistar; Spectrometry, X-Ray Emission

2008
Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Administration, Oral; Amlodipine; Animals; Antiprotozoal Agents; Dihydropyridines; Leishmania donovani; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Treatment Outcome

2008
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:9

    Topics: Adult; Aged; Aging; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Coronary Angiography; Coronary Stenosis; Coronary Vasospasm; Diabetes Complications; Dihydropyridines; Diltiazem; Ergonovine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nifedipine; Oxytocics; Prognosis; Risk Factors

2007
Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2008, Volume: 8, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Health Care Costs; Humans; Hypertension; Longitudinal Studies; Male; Medicaid; Patient Compliance; Retrospective Studies; South Carolina; United States

2008
Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Diseases; Cohort Studies; Coronary Vasospasm; Dihydropyridines; Diltiazem; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors

2008
Effects of calcium channel blockers on hyaluronidase-induced capillary vascular permeability.
    Archives of pharmacal research, 2008, Volume: 31, Issue:7

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Capillary Permeability; Carrageenan; Dihydropyridines; Hyaluronoglucosaminidase; Inflammation; Injections, Intravenous; Male; Nicardipine; Rats; Rats, Wistar

2008
Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists.
    American journal of hypertension, 2009, Volume: 22, Issue:2

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Chemokine CCL2; Dihydropyridines; Drug Synergism; Femoral Artery; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Neuropeptides; Nifedipine; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Superoxides; Tetrazoles; Tumor Necrosis Factor-alpha; Tunica Intima

2009
Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina.
    Experimental eye research, 2009, Volume: 88, Issue:5

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Drug Evaluation, Preclinical; In Situ Nick-End Labeling; Injections; Injections, Intravenous; Male; N-Methylaspartate; Neuroprotective Agents; Nitroso Compounds; omega-Conotoxins; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Degeneration; Retinal Diseases; Vitreous Body

2009
Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:4

    Topics: Adjuvants, Anesthesia; Amlodipine; Anesthesia; Animals; Atropine; Azetidinecarboxylic Acid; Baroreflex; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Coronary Vessels; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Heart Rate; Infusions, Intravenous; Injections, Intravenous; Pentobarbital; Perfusion; Propranolol; Sympathetic Nervous System; Time Factors

2009
Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
    American journal of nephrology, 2009, Volume: 30, Issue:2

    Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Conotoxins; Dihydropyridines; Humans; Male; Norepinephrine; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Time Factors

2009
Comparison of antioxidant activity of cilnidipine and amlodipine.
    Kidney international, 2009, Volume: 76, Issue:2

    Topics: Amlodipine; Antioxidants; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Mesangial Cells; Superoxides

2009
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
    British journal of pharmacology, 2009, Volume: 158, Issue:5

    Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors

2009
Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, 'real-world' comparison with amlodipine.
    Clinical drug investigation, 2009, Volume: 29, Issue:11

    Topics: Adult; Aged; Albuminuria; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, T-Type; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Retrospective Studies

2009
Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 106, Issue:2

    Topics: Amlodipine; Anesthetics, Inhalation; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Female; Halothane; Heart Rate; Heart Ventricles; Infusions, Intravenous; Male; Myocardial Contraction; Norepinephrine

2010
A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.
    European journal of pharmacology, 2010, Apr-25, Volume: 632, Issue:1-3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Amlodipine; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Electrophysiology; Female; Lysine; Microelectrodes; Oocytes; Patch-Clamp Techniques; Xenopus

2010
Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:2

    Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Creatinine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kaplan-Meier Estimate; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nifedipine; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome

2010
Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
    Cardiovascular therapeutics, 2011, Volume: 29, Issue:1

    Topics: Adult; Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Glucose; Humans; Hypertension; Kidney; Lipid Metabolism; Male; Middle Aged

2011
Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.
    Journal of hypertension, 2010, Volume: 28, Issue:5

    Topics: Amlodipine; Animals; Base Sequence; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, N-Type; Creatinine; Dihydropyridines; Disease Models, Animal; DNA Primers; Humans; Kidney; Male; Metabolic Syndrome; Oxidative Stress; Podocytes; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; RNA, Small Interfering; Triglycerides

2010
[Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2010, Volume: 30, Issue:4

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cardiomegaly; Dihydropyridines; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Nifedipine

2010
L-type calcium channel blockers and Parkinson disease in Denmark.
    Annals of neurology, 2010, Volume: 67, Issue:5

    Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Community Health Planning; Denmark; Dihydropyridines; Female; Humans; Logistic Models; Male; Middle Aged; Outpatients; Parkinson Disease; Prescription Drugs; Registries; Retrospective Studies

2010
Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:9

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Dihydropyridines; Drug Therapy, Combination; Gene Expression; Glomerulosclerosis, Focal Segmental; Hypertension; Irbesartan; Kidney Glomerulus; Male; NADPH Oxidases; Nitrophenols; Organophosphorus Compounds; Proteinuria; Rats; Rats, Inbred Dahl; Tetrazoles; Transforming Growth Factor beta

2010
The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet.
    Heart and vessels, 2010, Volume: 25, Issue:6

    Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Disease Models, Animal; Drug Therapy, Combination; Glomerulonephritis; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Tetrazoles; Time Factors; Valine; Valsartan

2010
Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:1

    Topics: Amlodipine; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Body Weight; Calcium Channel Blockers; Dihydropyridines; Down-Regulation; Gelatinases; Hypertension, Renovascular; Hypertrophy; Lipid Peroxides; Male; Matrix Metalloproteinase 2; Nifedipine; Nimodipine; Rats; Rats, Wistar; Reactive Oxygen Species; Tunica Media

2011
Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Dihydropyridines; Eplerenone; Humans; Hypertension, Renovascular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrotic Syndrome; Proteinuria; Radiography; Spironolactone; Treatment Outcome

2011
L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:4

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Collagen; Desoxycorticosterone; Dihydropyridines; Disease Models, Animal; Hypertension; Intracellular Signaling Peptides and Proteins; Kidney; Male; Membrane Proteins; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium Chloride; Transforming Growth Factor beta; Treatment Outcome

2011
Effects of an N-type calcium antagonist on angiotensin II-renin feedback.
    American journal of nephrology, 2011, Volume: 33, Issue:2

    Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Male; Models, Biological; Rats; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan

2011
Effects of hypertension and ovariectomy on rat hepatocytes. Are amlodipine and lacidipine protective? (A stereological and histological study).
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:4

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Cytoprotection; Dihydropyridines; Female; Hepatocytes; Hypertension; Liver; Ovariectomy; Postmenopause; Rats; Rats, Inbred Strains

2010
Comparative effects of azelnidipine and amlodipine on myocardial function and mortality after ischemia/reperfusion in dogs.
    Journal of pharmacological sciences, 2011, Volume: 116, Issue:2

    Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dog Diseases; Dogs; Energy Metabolism; Female; Male; Myocardium; Reperfusion Injury

2011
Intravascular ultrasound parameters in non-inferiority trial.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9

    Topics: Amlodipine; Azetidinecarboxylic Acid; Coronary Artery Disease; Dihydropyridines; Humans; Hypertension

2011
Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:1

    Topics: Amlodipine; Animals; Antihypertensive Agents; Bone and Bones; Bone Density; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Female; Osteoporosis; Ovariectomy; Rats; Rats, Inbred SHR

2012
Effects of calcium antagonists and agonists on isolated human v. saphena magna used for coronary artery bypass grafting and guinea pig's papillary muscle.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:7

    Topics: Action Potentials; Adult; Aged; Aged, 80 and over; Amlodipine; Animals; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Coronary Artery Bypass; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Papillary Muscles; Phenylephrine; Saphenous Vein; Vasoconstrictor Agents

2011
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.
    European journal of pharmacology, 2011, Nov-16, Volume: 670, Issue:1

    Topics: Amino Acid Sequence; Amlodipine; Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; HEK293 Cells; Humans; Molecular Sequence Data; Mutation; Nicardipine; Protein Conformation

2011
Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:3

    Topics: Amlodipine; Animals; Arterioles; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Heart Rate; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred Dahl; Sympathectomy; Sympathetic Nervous System

2012
[Shortening of donepezil-induced QTc prolongation with a change in the interacting drug, after electrocardiograph monitoring by community pharmacists: a case report].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:2

    Topics: Aged, 80 and over; Amlodipine; Cholinesterase Inhibitors; Community Pharmacy Services; Dihydropyridines; Donepezil; Drug Interactions; Electrocardiography, Ambulatory; Female; Humans; Indans; Pharmacists; Piperidines; Risk; Risk Management; Torsades de Pointes

2012
Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells.
    BMC research notes, 2012, Jul-06, Volume: 5

    Topics: Amlodipine; Anthracenes; Butadienes; Calcium Channel Blockers; Cell Proliferation; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lipoproteins, LDL; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Time Factors

2012
Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:7

    Topics: Aged; Aged, 80 and over; Amlodipine; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nitric Oxide; Treatment Outcome; Uric Acid

2012
Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
    Journal of hypertension, 2012, Volume: 30, Issue:9

    Topics: Amlodipine; Animals; Blotting, Western; Calcium Channel Blockers; Diastole; Dihydropyridines; Immunohistochemistry; Male; Myocardium; Oxidative Stress; Rats; Rats, Inbred Dahl; Reverse Transcriptase Polymerase Chain Reaction

2012
Action of calcium antagonists and agonists on isolated human thoracic arteries used for coronary artery bypass grafting.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Coronary Artery Bypass; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Pyridines; Thoracic Arteries

2012
Hypertension in older adults: progress and limitations.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Imidazoles; Male; Tetrazoles

2012
Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
    Clinical and experimental nephrology, 2013, Volume: 17, Issue:1

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Glucagon; Glucose Transporter Type 1; Glycated Hemoglobin; Glycogen; Hypertension; Kidney; Male; Norepinephrine; Proteinuria; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan

2013
The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Journal of cardiovascular pharmacology, 2013, Volume: 61, Issue:1

    Topics: Administration, Oral; Amlodipine; Angina Pectoris; Animals; Arginine Vasopressin; Azetidinecarboxylic Acid; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Male; Myocardium; Oxygen Consumption; Rats; Swine; Time Factors; Vasoconstriction

2013
Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats.
    American journal of physiology. Renal physiology, 2013, Mar-15, Volume: 304, Issue:6

    Topics: Actins; Amlodipine; Animals; Cadherins; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cell Proliferation; Dihydropyridines; Disease Models, Animal; Epithelial-Mesenchymal Transition; Kidney; Macrophages; Male; Rats; Rats, Wistar; Ureteral Obstruction

2013
Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice.
    Biochemical and biophysical research communications, 2013, May-03, Volume: 434, Issue:2

    Topics: Amlodipine; Angiotensin II; Animals; Aorta, Thoracic; Biomarkers; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Hypertension; Macrophages; Mice; omega-Conotoxin GVIA; Oxidative Stress; Reactive Oxygen Species; Vasodilation; Vasodilator Agents

2013
Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes.
    European journal of pharmacology, 2013, Sep-05, Volume: 715, Issue:1-3

    Topics: Amlodipine; Angiotensin Receptor Antagonists; Animals; Azetidinecarboxylic Acid; Biomechanical Phenomena; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Imidazoles; Mechanical Phenomena; Mice; Myocytes, Cardiac; Single-Cell Analysis; Tetrazoles

2013
The role of external Ca²⁺ in the action of Ca²⁺-channel agonists and antagonists on isolated human thoracic arteries.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2014, Volume: 65, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Female; Humans; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Milrinone; Thoracic Arteries

2014
Discovering the sympathomodulatory properties of new calcium channel blockers: an exciting but still snaky journey.
    Journal of hypertension, 2014, Volume: 32, Issue:9

    Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Baroreflex; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Male; Sympathetic Nervous System

2014
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:3

    Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan

2015
Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:1

    Topics: Amlodipine; Animals; Antihypertensive Agents; Dihydropyridines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Oxidative Stress; Rats, Inbred Dahl; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2015
Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:12

    Topics: Adolescent; Amlodipine; Calcium Channel Blockers; Child; Child, Preschool; Cyclosporine; Dihydropyridines; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Hypertension; Immunosuppressive Agents; Infant; Male; Nicardipine; Retrospective Studies

2014
Continuous venovenous hemodiafiltration along with charcoal hemoperfusion for the management of life-threatening lercanidipine and amlodipine overdose.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:6

    Topics: Aged; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Charcoal; Dihydropyridines; Drug Overdose; Hemodiafiltration; Hemoperfusion; Humans; Male; Multiple Organ Failure; Shock; Time Factors; Treatment Outcome

2014
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles

2015
Cilnidipine but not amlodipine suppresses sympathetic activation elicited by isometric exercise in hypertensive patients.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:7

    Topics: Aged; Amlodipine; Autonomic Nervous System; Calcium Channel Blockers; Dihydropyridines; Exercise; Female; Hand Strength; Humans; Hypertension; Male; Middle Aged; Miosis; Mydriasis; Pupil; Reproducibility of Results

2015
Effects of Administration of Amlodipine and Lacidipine on Inflammation-Induced Bone Loss in the Ovariectomized Rat.
    Inflammation, 2016, Volume: 39, Issue:1

    Topics: Amlodipine; Animals; Bone Density; Calcium Channel Blockers; Collagen Type I; Collagen Type I, alpha 1 Chain; Core Binding Factor Alpha 1 Subunit; Dihydropyridines; Female; Humans; Hypertension; Inflammation; Interleukin-1beta; Interleukin-6; Osteocalcin; Osteopontin; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2016
Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2016, Volume: 38, Issue:2

    Topics: Aged; Alanine Transaminase; Amlodipine; Antihypertensive Agents; Aspartate Aminotransferases; Azetidinecarboxylic Acid; Benzimidazoles; Biphenyl Compounds; Blood Urea Nitrogen; Cohort Studies; Creatinine; Dihydropyridines; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Potassium; Propensity Score; Retrospective Studies; Sodium; Tetrazoles; Uric Acid

2016
Failure of intravenous lipid emulsion in treatment of cardiotoxicity caused by mixed overdose including dihydropyridine calcium channel blockers.
    Vojnosanitetski pregled, 2016, Volume: 73, Issue:1

    Topics: Adult; Amlodipine; Calcium Channel Blockers; Cardiotoxicity; Dihydropyridines; Emergencies; Fat Emulsions, Intravenous; Fatal Outcome; Female; Heart Arrest; Humans; Male; Treatment Failure

2016
Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2016, Volume: 39, Issue:12

    Topics: Amlodipine; Antihypertensive Agents; Autonomic Nervous System; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Essential Hypertension; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Pupil

2016
On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
    Bioscience reports, 2016, Volume: 36, Issue:5

    Topics: Aged; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Renin-Angiotensin System; Valsartan

2016
Structural basis for inhibition of a voltage-gated Ca
    Nature, 2016, 09-01, Volume: 537, Issue:7618

    Topics: Allosteric Regulation; Amines; Amlodipine; Animals; Bacterial Proteins; Binding Sites; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line; Crystallography, X-Ray; Dihydropyridines; Lipids; Models, Molecular; Moths; Mutation; Niacin; Protein Subunits; Verapamil

2016
Cilnidipine: Next Generation Calcium Channel Blocker.
    The Journal of the Association of Physicians of India, 2016, Volume: 64, Issue:4

    Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Humans; Hypertension; India; Middle Aged

2016
Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017, Volume: 24, Issue:1

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Substitution; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Product Surveillance, Postmarketing; Prospective Studies; Time Factors; Treatment Outcome

2017
[The Effectiveness of Combination Antihypertensive Therapy in Women With Hypothyroidism and the Metabolic Syndrome].
    Kardiologiia, 2016, Volume: 56, Issue:9

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Hypothyroidism; Imidazoles; Losartan; Metabolic Syndrome; Middle Aged

2016
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
    Current medical research and opinion, 2017, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Stroke; Taiwan; Young Adult

2017
Effects of L- and N-Type Ca Channel Blocker Cilnidipine on Changes in Heart Rate and QT Interval During Dialysis.
    Kidney & blood pressure research, 2017, Volume: 42, Issue:5

    Topics: Aged; Amlodipine; Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Renal Dialysis; Sympathetic Nervous System

2017
Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2018, Volume: 41, Issue:4

    Topics: Aged; Amlodipine; Ankle Brachial Index; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Catecholamines; Dihydropyridines; Female; Humans; Hypertension; Male; Prospective Studies; Sympathetic Nervous System; Vascular Stiffness

2018
Moderate hypothermia and responses to calcium channel blockers - Role of the nitric oxide.
    Physiology international, 2018, Mar-01, Volume: 105, Issue:1

    Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cold Temperature; Coronary Vessels; Dihydropyridines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypothermia, Induced; In Vitro Techniques; Nitric Oxide; Nitric Oxide Synthase Type III; Vasodilation; Vasodilator Agents; Verapamil

2018
Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
    BMC nephrology, 2019, 01-03, Volume: 20, Issue:1

    Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diabetic Nephropathies; Dihydropyridines; Drug Substitution; Edema; Everolimus; Humans; Hypertension; Indazoles; Kidney Failure, Chronic; Lung Neoplasms; Male; Nephrotic Syndrome; Nivolumab; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrimidines; Sirolimus; Sulfonamides; Sunitinib

2019
Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): "Issues with hypertension studies in real-world practice".
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2020, Jul-03, Volume: 42, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Drug Combinations; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Japan; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome

2020
Single-pill combination of cilnidipine, an L-/N-type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE-Combi survey.
    Journal of clinical hypertension (Greenwich, Conn.), 2020, Volume: 22, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Humans; Hypertension; Tetrazoles; Valsartan

2020
Comparison of effects of L/N-type and L-type calcium channel blockers on post-infarct cardiac remodelling in spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:9

    Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Calcium Signaling; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hypertension; Male; Myocardial Infarction; Norepinephrine; Rats, Inbred SHR; Renin-Angiotensin System; Ventricular Function, Left; Ventricular Remodeling

2020
Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca
    Angewandte Chemie (International ed. in English), 2021, 02-08, Volume: 60, Issue:6

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Binding Sites; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cryoelectron Microscopy; Dihydropyridines; Molecular Dynamics Simulation; Nanostructures; Protein Structure, Tertiary; Stereoisomerism

2021
Single-pill combination of cilnidipine, an l-/n-type calcium channel blocker, and valsartan reduces the day-by-day variability of morning home systolic blood pressure in patients with treated hypertension: A sub-analysis of the HOPE-combi survey.
    Journal of clinical hypertension (Greenwich, Conn.), 2021, Volume: 23, Issue:2

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Humans; Hypertension; Tetrazoles; Valsartan

2021
Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin.
    Toxicology in vitro : an international journal published in association with BIBRA, 2021, Volume: 74

    Topics: Amlodipine; Antibiotics, Antineoplastic; Calcium Channel Blockers; Cell Line; Cell Survival; Dihydropyridines; Doxorubicin; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Stomach Neoplasms; Transcription, Genetic; Transcriptome; Transforming Growth Factor beta; YY1 Transcription Factor

2021
Cilnidipine for Amlodipine Induced Pedal Edema and its Anti-hypertensive Effect in a Tertiary Care Teaching Hospital of Western Nepal.
    Journal of Nepal Health Research Council, 2021, Dec-15, Volume: 19, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Edema; Hospitals, Teaching; Humans; Male; Middle Aged; Nepal; Prospective Studies; Tertiary Healthcare

2021
Gingival enlargement improvement following medication change from amlodipine to benidipine and periodontal therapy.
    BMJ case reports, 2022, May-19, Volume: 15, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Female; Gingival Hyperplasia; Gingival Overgrowth; Humans; Hypertension

2022
Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.
    The journal of prevention of Alzheimer's disease, 2022, Volume: 9, Issue:4

    Topics: Adrenergic Antagonists; Adult; Aged; Amlodipine; Antihypertensive Agents; Apolipoprotein E4; Calcium Channel Blockers; Cognition; Cohort Studies; Dihydropyridines; Diuretics; Diuretics, Potassium Sparing; Genotype; Humans; Hypertension; Nifedipine; Thiazides; Vasodilator Agents

2022